From insight to impact
What is Catalyst?
Catalyst is a program at the Massachusetts Institute of Technology (MIT) linQ that drives biomedical innovation by addressing real, unmet health needs through emerging technologies. It brings together multidisciplinary teams of researchers, clinicians, designers, and entrepreneurs to identify unmet needs, generate technological opportunities, and develop projects with strong commercial or clinical potential. Catalyst has achieved remarkable success at MIT—around 50% of its projects advance toward commercial development, compared to the institute’s overall average of about 15%.
Why Catalyst? Key differences vs. the traditional paradigm
Traditional
- Primary focus on production of new knowledge.
- Strong incentives to “go with what you know”; risk discouraged or impeded
- PI-centric: They drive program and manage all aspects (administrative, mentoring, planning, …)
- Performance requirements tend to reinforce professional and organizational silos
- Hierarchical training system
Catalyst
- Primary focus on improved outcomes and impact; knowledge generation a natural by-product
- Problem-focus is technology-agnostic; incentives to solve problem by best means available
- Resources aligned with expertise to maximize results and include new contributors.
- Clear goals and timelines foster cross-professional and institutional collaboration.
- 360º learning opportunities
Process Phases
Phase 1: Opportunity Discovery
- Landscape exploration (users, data, regulations, alternatives).
- Interviews and user/patient journey mapping.
- Explicit hypotheses and kill criteria.
- Proposed proof-of-principle and study plan.
Phase 2: Execution & Validation
- Prototype and efficacy/feasibility studies.
- Value metrics and market evaluation.
- IP strategy and funding pathway.
- Team growth and partnerships (labs, test sites).
Roles & Community
- Fellows: diverse profiles with 360º learning.
- Mentors/Faculty: ongoing commitment that weaves the ecosystem.
- Advisory Panel: domain experts for critical decisions.
- External Partners: companies, labs, public bodies.
ASCENT 